Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CamDiab logo — CamAPS® FX app that automatically adjusts insulin delivery o...

CamDiab

CamAPS® FX app that automatically adjusts insulin delivery on an insulin pump based on sensor glucose readings.

Founded 2018 United Kingdom Cambridge, United Kingdom 6 employees Health Care, Information Technology

General Information

Company Name CamDiab
Founded Year 2018
Location United Kingdom Cambridge, United Kingdom +1
Employees 6
Industries Health Care, Information Technology
Social

Get notified when CamDiab moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CamDiab

CamDiab is a UK-based startup that has developed the CamAPS® FX, an advanced, adaptive, hybrid closed-loop app for people living with type 1 diabetes. This innovative app automatically adjusts insulin delivery via an insulin pump based on sensor glucose readings, offering a convenient and efficient solution for diabetes management. Established in 2006, CamDiab operates within the Health Care and Information Technology industries, catering to a diverse demographic including individuals as young as 1 year old as well as pregnant women. Despite the absence of publicly disclosed recent investments and investors, CamDiab's cutting-edge technology and its potential to revolutionize diabetes management make it an intriguing prospect for venture capital investment. The company's commitment to addressing an increasingly prevalent health concern with technology-driven solutions positions it as an attractive investment opportunity within the healthcare and technology sectors.

Taxonomy: Closed-Loop, Insulin, Type 1 Diabetes, Artificial Pancreas, Diabetes Technology, Hybrid Closed-Loop Insulin Delivery

No funding data available for CamDiab yet.

Get notified when CamDiab raises funding

CamDiab Alternatives & Competitors

CamDiab vs
Portal Diabetes, Inc.
Portal Diabetes, Inc. United States

Freedom for people who use insulin.

Corporate Round
17 employees
Biotechnology, Health Care
CamDiab vs
Diatech Diabetes, Inc.
Diatech Diabetes, Inc. United States

Personalizing Insulin Delivery for People with Diabetes

Debt Financing
7 employees
Health Care, Medical Devices
CamDiab vs
KUTU
KUTU Turkey

Smart insulin pump for diabetics

93 employees
Digital Health, Health Care

FAQ About CamDiab

CamAPS® FX app that automatically adjusts insulin delivery on an insulin pump based on sensor glucose readings.
CamDiab was founded in 2018.
CamDiab is headquartered in Cambridge, United Kingdom.
CamDiab operates in the following industries: Health Care, Information Technology.
CamDiab has approximately 6 employees.
Top alternatives and competitors to CamDiab include Portal Diabetes, Inc., Diatech Diabetes, Inc., KUTU, Tandem Diabetes Care Switzerland, HYGIEIA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CamDiab and Portal Diabetes, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CamDiab and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy